OrbiMed’s ImageneBio Inc IMA Stock Holding History

OrbiMed’s Portfolio IMA Stock Details IMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.36M	Buy	909,269 +530,713	+140%	+$3M	0.1%	101
2026 Q1	$1.89M	Hold	378,556	–	–	0.04%	108
2025 Q4	$2.61M	Hold	378,556	–	–	0.05%	97
2025 Q3	$3.09M	Buy	378,556 +83,609	+28%	+$1.11M	0.07%	96
2025 Q2	$4.74M	Hold	294,947	–	–	0.12%	79
2025 Q1	$4.53M	Hold	294,947	–	–	0.11%	80
2024 Q4	$5.8M	Hold	294,947	–	–	0.12%	82
2024 Q3	$6.12M	Hold	294,947	–	–	0.11%	91
2024 Q2	$5.84M	Hold	294,947	–	–	0.12%	85
2024 Q1	$5.03M	Hold	294,947	–	–	0.09%	96
2023 Q4	$6.97M	Buy	294,947 +29,433	+11%	+$960K	0.14%	86
2023 Q3	$13.8M	Hold	265,514	–	–	0.29%	71
2023 Q2	$20.9M	Hold	265,514	–	–	0.38%	69
2023 Q1	$11M	Buy	265,514 +21,019	+9%	+$966K	0.22%	83
2022 Q4	$7.8M	Hold	244,495	–	–	0.15%	83
2022 Q3	$10.4M	Hold	244,495	–	–	0.19%	83
2022 Q2	$13M	Hold	244,495	–	–	0.24%	79
2022 Q1	$17.9M	Hold	244,495	–	–	0.29%	70
2021 Q4	$36.8M	Hold	244,495	–	–	0.47%	59
2021 Q3	$37M	Hold	244,495	–	–	0.41%	69
2021 Q2	$41.2M	Hold	244,495	–	–	0.42%	66
2021 Q1	$82.9M	Buy	+244,495	New	+$83.7M	0.78%	39

Other funds holding IMA

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

BOCH

Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return

CCC

Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

TECP

Trails Edge Capital Partners Atlanta, Georgia $630M AUM

BCM

BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

MIM

Monashee Investment Management Boston, Massachusetts $59.6M AUM 181.61% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

OrbiMed's IMA Position: Q2 2026 in Review

OrbiMed increased its ImageneBio Inc (IMA) stake by 140% in Q2 2026, buying an estimated $3M and bringing the position to 909,269 shares worth $5.36M. The position accounts for 0.1% of the portfolio, ranked #101.

OrbiMed first reported a position in IMA in Q1 2021 and has held it in 22 quarters since. The position peaked at $82.9M in Q1 2021. 35 funds tracked by Wall St. Rank hold IMA as of Q2 2026.

OrbiMed held 909,269 shares of ImageneBio Inc worth $5.36M as of Q2 2026.
OrbiMed bought 530,713 ImageneBio Inc shares in Q2 2026, an estimated $3M.
ImageneBio Inc made up 0.1% of OrbiMed's portfolio in Q2 2026, its #101 holding.
OrbiMed first reported a position in ImageneBio Inc in Q1 2021 and has held it in 22 quarters since.
OrbiMed's ImageneBio Inc position peaked at $82.9M in Q1 2021.
35 funds tracked by Wall St. Rank held ImageneBio Inc as of Q2 2026.

Based on OrbiMed's 13F filing for Q2 2026, filed 14 Aug 2026.